Profile
AARD CLBAX MER-PK FFICX CICAX FUNFX
Company Name Aardvark Therapeutics, Inc. Common Stock American Funds American Balanced 529A Merrill Lynch Capital Trust I GTD CAP 6.45% American Funds Invmt Co of Amer F3 American Funds Invmt Co of Amer 529A American Funds Fundamental Invs F3
Sector - - - - - -
Industry - - - - - -
Market Cap $2.27B $241.63B $201.90B $159.92B $158.97B $145.14B
Employees 0.02K 0.00K 0.00K 0.00K 0.00K 0.00K
CEO Dr. Tien-Li Lee M.D. - - - - -
Ratings
AARD CLBAX MER-PK FFICX CICAX FUNFX
Quant Rating Score 3
Quant Rating Neutral
Trading
AARD CLBAX MER-PK FFICX CICAX FUNFX
Last Close $17.25 $35.6 $25.78 $60.51 $60.29 $84.9
High 52 $17.11 $37.11 $26.61 $64.42 $64.19 $90.94
Low 52 - $33.05 $25.15 $55.01 $53.72 $76.72
Price vs. 52 Week High 0.82 % -4.07 % -3.12 % -6.07 % -6.08 % -6.64 %
Price vs. 52 Week Low 0 % 7.72 % 2.5 % 10 % 12.23 % 10.66 %
Total Return
AARD CLBAX MER-PK FFICX CICAX FUNFX
1 Month Return 0 % 1.92 % -0.77 % 2.68 % 2.66 % 1.88 %
3 Month Return 0 % -1.71 % -1.75 % -2.09 % -2.11 % -2.58 %
6 Month Return 0 % 0.2 % -0.08 % 2.77 % 2.74 % 2.17 %
9 Month Return 0 % 4.77 % 1.5 % 0 % 7.05 % 4.71 %
YTD Return 0 % 3.91 % 0.39 % 4.98 % 4.93 % 5.26 %
1 Year Return 0 % 0 % 0.78 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AARD CLBAX MER-PK FFICX CICAX FUNFX
Dividend Yield Percentage (TTM) - 1.99 % - 1.31 % 0.99 % 1.38 %
Dividend Paid and Capex Coverage Ration (TTM) - - -9.1 % - - -
Dividend Per Share (TTM) - 0.71 % - 0.79 % 0.6 % 1.17 %
Payout Ratio (TTM) - - 26.64 % - - -
Income Statement (TTM)
AARD CLBAX MER-PK FFICX CICAX FUNFX
Revenue $94.95B
Gross Profit $58.5B
Gross Profit Ratio 61.61%
EBITDA $32.95B
Net Income $27.53B
EPS Diluted 3.37
Balance Sheet (MRQ)
AARD CLBAX MER-PK FFICX CICAX FUNFX
Long Term Debt $302.2B
Total Liabilities $2888.51B
Total Equity $291.65B
Total Investments $8.35B
Total Debt $342.76B
Total Assets $3180.15B
Cash Flow Statement (TTM)
AARD CLBAX MER-PK FFICX CICAX FUNFX
Net Income $27.53B
Inventory $0B
Dividends Paid $0B
Operating Cash Flow $-6.33B
Capital Expenditure $0B
Related Stocks
Ticker Name Price
AAACX Alpha Alternative Assets Fund 6.42
AAC-WT Ares Acquisition Corporation Re 0.63
AACQU Artius Acquisition Inc. 11.05
AADEX American Beacon Large Cap Value R5 27.59
AAIDX Axonic Alternative Income Fund 20.38
AAIN Arlington Asset Investment Corp 23.5
AAQC-WT 0.0057
AARTX Stone Ridge Trust VIII 10.62
ABRTX ABR DYNAMIC BLEND EQUITY & VOLATILITY FUND - INVESTOR SHARES 11.37
ACCNX American Century Core Plus Fd Investor Cl 9.13
ACHR-WT 3.0299
ACRO-WT 0.0105
ADEX-WT Adit EdTech Acquisition Corp. R 0.084
ADILW Adial Pharmaceuticals, Inc. WT EXP 073123 0.0009
ADRA-WT Adara Acquisition Corp. 0.0488
AEMGX Acadian Emerging Markets Portfolio Investor Class 23.79
AEVA-WT Aeva Technologies, Inc. Redeema 0.0693
AFDVX Applied Finance Explorer fund Investor Class 22.1
AFJKR Aimei Health Technology Co., Ltd Right 0.2571
AFTR-WT 0.0041
Unlock